Comments on: Life sciences briefing: Monday, Oct. 22, 2007 http://venturebeat.com/2007/10/22/life-sciences-briefing-monday-oct-22-2007/ News About Tech, Money and Innovation Wed, 25 Nov 2009 08:36:57 +0000 http://wordpress.org/?v=2.8.5 hourly 1 By: VentureBeat » Life sciences briefing: Wednesday, Nov. 7, 2007 http://venturebeat.com/2007/10/22/life-sciences-briefing-monday-oct-22-2007/comment-page-1/#comment-621154 VentureBeat » Life sciences briefing: Wednesday, Nov. 7, 2007 Wed, 07 Nov 2007 21:42:01 +0000 http://venturebeat.com/2007/10/22/life-sciences-briefing-monday-oct-22-2007/#comment-621154 [...] its maximum take from the offering to $92 million from $127 million. (See our earlier coverage here and here.) The company priced the offering at $8 a share, although investors pushed up the price 55 [...] [...] its maximum take from the offering to $92 million from $127 million. (See our earlier coverage here and here.) The company priced the offering at $8 a share, although investors pushed up the price 55 [...]

]]> By: VentureBeat » Cosmetic-procedures product maker BioForm aims for $127M IPO http://venturebeat.com/2007/10/22/life-sciences-briefing-monday-oct-22-2007/comment-page-1/#comment-591432 VentureBeat » Cosmetic-procedures product maker BioForm aims for $127M IPO Tue, 23 Oct 2007 01:16:28 +0000 http://venturebeat.com/2007/10/22/life-sciences-briefing-monday-oct-22-2007/#comment-591432 [...] our story on this San Mateo, Calif., “medical aesthetics” company in today’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...] [...] our story on this San Mateo, Calif., “medical aesthetics” company in today’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...]

]]> By: VentureBeat » SarCode draws in $7M for inflammation drugs http://venturebeat.com/2007/10/22/life-sciences-briefing-monday-oct-22-2007/comment-page-1/#comment-590788 VentureBeat » SarCode draws in $7M for inflammation drugs Mon, 22 Oct 2007 16:06:03 +0000 http://venturebeat.com/2007/10/22/life-sciences-briefing-monday-oct-22-2007/#comment-590788 [...] our story on this San Francisco biotech in today’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...] [...] our story on this San Francisco biotech in today’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...]

]]>